We are live on ! Find out more
ATXS

Astria Therapeutics

Delisted

ATXS was delisted on the 22nd of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$3.84M
FFM
2
Fairmount Funds Management
Pennsylvania
$2.73M
RCM
3
RA Capital Management
Massachusetts
$2.28M -$2.25M -501,336 -40%
IC
4
Ikarian Capital
Texas
$1.78M +$2.24M +499,900 +542%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.51M -$131K -29,158 -5%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$1.13M +$106K +23,561 +7%
CAM
7
Cormorant Asset Management
Massachusetts
$900K
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$824K
Citadel Advisors
9
Citadel Advisors
Florida
$659K -$107K -23,827 -10%
BCM
10
Bridgeway Capital Management
Texas
$343K +$224K +50,000 +78%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$252K +$27.3K +6,089 +8%
BFM
12
Boothbay Fund Management
New York
$227K +$340K +75,773 New
BlackRock
13
BlackRock
New York
$185K +$49.6K +11,071 +22%
AG
14
Artal Group
Luxembourg
$100K
AI
15
ArchPoint Investors
Florida
$77K
SB
16
Samsara BioCapital
California
$75K
OC
17
Oppenheimer & Co
New York
$71K
Northern Trust
18
Northern Trust
Illinois
$60K -$852 -190 -0.9%
Millennium Management
19
Millennium Management
New York
$51K +$75.8K +16,917 New
Renaissance Technologies
20
Renaissance Technologies
New York
$41K +$61.4K +13,700 New
Group One Trading
21
Group One Trading
Illinois
$34K
Morgan Stanley
22
Morgan Stanley
New York
$8K -$2.27K -507 -17%
TRCT
23
Tower Research Capital (TRC)
New York
$6K +$7.47K +1,666 +409%
Bank of America
24
Bank of America
North Carolina
$2K +$2.47K +550 +3,667%
BFEC
25
Benjamin F. Edwards & Company
Missouri
$1K